MedPath

A Dose-Response Study of Human Unacylated Ghrelin on Glycemia during Oral Glucose Tolerance Test inPatients with Type 2 Diabetes Mellitus.

Conditions
diabetesghrelininsulin
Registration Number
NL-OMON27562
Lead Sponsor
none
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

1. Female or Male subject of 18 years of age or older;

2. Documented diagnosis of type 2 diabetes as defined by American Diabetes Association;

Exclusion Criteria

1. History of or presence of active concomitant conditions or disease that would interfere with the protocol conduct
and study assessments, as judged by the investigator;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath